8-chloro-cyclic adenosine monophosphate has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adzić, M; Nićiforović, A; Radojcić, MB; Ruzdijić, S; Vucić, V | 1 |
| Dodds, M; Howie, AF; Langdon, SP; Leonard, RC; Miller, WR; Muir, M; Ritchie, AA; Stockman, PK | 1 |
2 other study(ies) available for 8-chloro-cyclic adenosine monophosphate and Cancer of Prostate
| Article | Year |
|---|---|
The combination of gamma ionizing radiation and 8-Cl-cAMP induces synergistic cell growth inhibition and induction of apoptosis in human prostate cancer cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Modality Therapy; Gamma Rays; Humans; Male; Prostatic Neoplasms | 2008 |
Antitumour activity and schedule dependency of 8-chloroadenosine-3',5'-monophosphate (8-ClcAMP) against human tumour xenografts.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antineoplastic Agents; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypercalcemia; Infusions, Intravenous; Male; Mice; Neoplasm Transplantation; Ovarian Neoplasms; Prostatic Neoplasms; Transplantation, Heterologous; Weight Loss | 1998 |